Skip to main content

Table 1 Clinicopathologic characteristics of triple-negative breast cancer (TNBC)

From: The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer

Characteristics

n (%)

Age (years)

< 60

196 (86.3%)

≥ 60

31 (13.7%)

Tumor size (cm)

≤ 2

82 (36.1%)

> 2

145 (63.9%)

Nuclear score

Score 1

0 (0%)

Score 2

45 (19.8%)

Score 3

182 (80.2%)

Histologic grade

Grade 1

0 (0%)

Grade 2

40 (17.6%)

Grade 3

187 (82.4%)

Ductal carcinoma in situ

Absent

96 (57.7%)

Present

131 (42.3%)

Lymphovascular invasion

Absent

92 (40.5%)

Present

135 (59.5%)

Lymph node metastasis

Absent

154 (67.8%)

Present

73 (32.2%)

Anatomic stage

Stage I

61 (26.9%)

Stage II

128 (56.4%)

Stage III

38 (16.7%)

Prognostic stage

Stage I

0 (0%)

Stage II

62 (27.3%)

Stage III

165 (72.7%)